ArticleNeuromolecular medicine2026
Early-Age Cuprizone Exposure Induces Region-Specific Demyelination and Neuroinflammation in Mice.
Article in Neuromolecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelin, essential for rapid nerve conduction and axonal integrity in the central and peripheral nervous systems, is compromised in demyelinating diseases, leading to neurological deficits and progressive neurodegeneration. Although remyelination can occur, regeneration in adults is often limited, resulting in incomplete repair and impaired nerve function. In multiple sclerosis (MS), an immune-mediated demyelinating disease with diverse clinical phenotypes, progression and disability correlate with demyelination and failed remyelination, influenced by genetic and environmental factors. A well-established method to study MS-like demyelination and its cellular and molecular mechanisms utilizes cuprizone (CPZ), extensively studied in adult rodents. Although early-onset demyelination often causes lifelong disability, its pathophysiology remains poorly understood, underscoring the need for models to dissect its biological features. Here, we characterized the effects of early-age CPZ-induced demyelination in juvenile naïve mice, focusing on region-specific vulnerability and neuroinflammatory responses. One-month-old mice were exposed to 0.2% CPZ for five weeks, followed by behavioral, cellular, and transcriptomic analyses. Susceptibility to the early-exposure of CPZ varied between the analysed brain regions. The midline corpus callosum and motor cortex were highly vulnerable, showing marked reductions in myelin together with elevated microglial activation. Other regions, including the hippocampus and amygdala, showed milder susceptibility, often restricted to changes in Mbp or Iba1 transcript levels without corresponding alterations in oligodendrocyte or microglial cell numbers. Behaviorally, early CPZ exposure reduced locomotor activity but did not produce robust anxiety-like or cognitive deficits. Together, these findings reveal distinct regional patterns of early-onset demyelination and neuroinflammation and support CPZ exposure in juvenile mice as a relevant model for multifocal juvenile demyelination, including paediatric-onset MS, and its impact on neurodevelopment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.